UBS Upgrades Corcept Therapeutics to Buy, Raises Price Target to $72
Corcept Therapeutics Inc CORT
$60.22
▲ +0.89%
(+$0.53)
Open
$60.00
Prev Close
$59.69
Day Range
$59.54 – $60.95
52W Range
$28.66 – $91.00
Market Cap
$6.46B
P/E (TTM)
136.55
Beta
0.42
EPS (TTM)
$0.35
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2004-04-15 |
| Shares Out. | 107,350,000 |
| Website | corcept.com/ ↗ |
| Phone | 13026587581 |
Corcept Therapeutics Inc is a publicly traded company under the ticker symbol CORT on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-05-01)